Dr. Alumkal's research interest is cancer epigenetics, the study of heritable and potentially reversible changes in gene expression in cancer. His laboratory studies key chromatin modifying enzymes in cancer with an eye towards: 1) elucidating their function and role in transformation and disease progression and 2) targeting them with pharmacological agents in order to improve our ability to prevent and treat men with prostate cancer. Finally, his laboratory also focuses on the identification of biomarkers associated with prostate cancer development or aggressiveness.
- M.D., Baylor College of Medicine 1998
- University of Texas, Southwestern Medical Center, 2002
- Fellowship in medical oncology, Johns Hopkins University School of Medicine, 2006
- American Board of Internal Medicine (internal medicine), 2001
Memberships and associations
- American College of Physicians